James B Froehlich
Clinical Professor of Internal Medicine
Medical Director of Domino's Farms Anti-Coagulation Clinic
Associate Chair, Department of Internal Medicine
Cardiovascular Medicine
1500 E. Medical Center Drive, SPC 5853
Ann Arbor, MI 48109-5853
[email protected]

Available to mentor
James B Froehlich
Clinical Professor
  • Qualifications
  • Center Memberships
  • Recent Publications
    • Qualifications
    • AB
      Dartmouth College, Hanover, 1982
    Center Memberships
    • Center Member
      Samuel and Jean Frankel Cardiovascular Center
    • Center Member
      Institute for Healthcare Policy and Innovation
    Recent Publications See All Publications
    • Journal Article
      Comparing DOAC and warfarin outcomes in an obese population using the 'real-world' Michigan Anticoagulation Quality Improvement Initiative (MAQI2) registry.
      Ardeshna N, Feldeisen T, Kong X, Haymart B, Kaatz S, Ali M, Barnes GD, Froehlich JB. Vasc Med, 2024 Oct; 29 (5): 543 - 552. DOI:10.1177/1358863X241264478
      PMID: 39177515
    • Journal Article
      Timing of Off-Label Dosing of Direct Oral Anticoagulants in Three Large Health Systems.
      Herron GC, DeCamillo D, Kong X, Haymart B, Kaatz S, Ellsworth S, Ali MA, Giuliano C, Froehlich JB, Barnes GD. Thromb Haemost, 2024 Jul 30; DOI:10.1055/a-2365-8681
      PMID: 39009007
    • Journal Article
      474 THE EFFECT OF A MULTICOMPONENT INTERVENTION ON GASTROINTESTINAL BLEEDING RISK IN PATIENTS PRESCRIBED WARFARIN: THE ANTICOAGULATION WITH ENHANCED GASTROINTESTINAL SAFETY (AEGIS) RANDOMIZED TRIAL
      Kurlander JE, Helminski D, Tao X, Saini SD, Krein S, Richardson CR, Kidwell KM, Lanham M, Henstock J, De Vries R, Resnicow K, Ha N, Haymart B, Alexandris-Souphis C, Froehlich JB, Barnes G. Gastroenterology, 2024 May; 166 (5): s - 105. DOI:10.1016/s0016-5085(24)00736-4
    • Journal Article
      Feasibility and acceptability of patient- and clinician-level antithrombotic stewardship interventions to reduce gastrointestinal bleeding risk in patients using warfarin (Anticoagulation with Enhanced Gastrointestinal Safety): a factorial randomized controlled pilot trial.
      Kurlander JE, Helminski D, Yuan L, Krein SL, Lanham MSM, Henstock JL, Kidwell KM, De Vries R, Resnicow K, Sholl H, Kim JJ, Perry LK, Parsons J, Ha N, Froehlich JB, Aikens JE, Richardson CR, Saini SD, Barnes GD. Res Pract Thromb Haemost, 2024 May; 8 (4): 102421 DOI:10.1016/j.rpth.2024.102421
      PMID: 38827255
    • Journal Article
      Outcomes of direct oral anticoagulants with aspirin vs warfarin with aspirin: a registry-based cohort study.
      Schaefer JK, Errickson J, Kong X, Ali MA, DeCamillo D, Edupuganti S, Haymart B, Kaatz S, Kline-Rogers E, Kozlowski JH, Krol GD, Sood SL, Froehlich JB, Barnes GD. Res Pract Thromb Haemost, 2024 May; 8 (4): 102449 DOI:10.1016/j.rpth.2024.102449
      PMID: 38983902
    • Journal Article
      Prevalence of Guideline-Discordant Aspirin Use and Associated Adverse Events in Patients on Warfarin for Mechanical Valve Replacement.
      Haymart B, Kong X, Ali M, Schaefer JK, Froehlich JB, Ryan N, Stallings B, Barnes GD, Kaatz S. Am J Med, 2024 May; 137 (5): 449 - 453. DOI:10.1016/j.amjmed.2024.01.015
      PMID: 38280559
    • Proceeding / Abstract / Poster
      A Comparison of Bleeding Events Among Patients on Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism
      Schaefer JK, Errickson J, Kong X, Ali MA, Chipalkatti N, Haymart B, Kaatz S, Krol GD, Sood SL, Froehlich J, Barnes GD. Blood, 2023 Nov 2; 142 (Supplement 1): 135 DOI:10.1182/blood-2023-184457
    • Proceeding / Abstract / Poster
      Outcomes of Oral Anticoagulation with Concomitant NSAID Use: A Registry Based Cohort Study
      Schaefer JK, Errickson J, Kong X, Ali MA, Chipalkatti N, Dorby P, Giuliano C, Haymart B, Kaatz S, Kurlander JE, Krol GD, Shankar S, Sood SL, Froehlich J, Barnes GD. Blood, 2023 Nov 2; 142 (Supplement 1): 5129 DOI:10.1182/blood-2023-184907